Design, Synthesis, and Biological Evaluation of 6-Substituted Thieno[3,2- d]pyrimidine Analogues as Dual Epidermal Growth Factor Receptor Kinase and Microtubule Inhibitors. 2019

Romeo Romagnoli, and Filippo Prencipe, and Paola Oliva, and Stefania Baraldi, and Pier Giovanni Baraldi, and Santiago Schiaffino Ortega, and Mariem Chayah, and Maria Kimatrai Salvador, and Luisa Carlota Lopez-Cara, and Andrea Brancale, and Salvatore Ferla, and Ernest Hamel, and Roberto Ronca, and Roberta Bortolozzi, and Elena Mariotto, and Elena Mattiuzzo, and Giampietro Viola
Dipartimento di Scienze Chimiche e Farmaceutiche , Università degli Studi di Ferrara , Via Luigi Borsari 46 , 44121 Ferrara , Italy.

The clinical evidence for the success of tyrosine kinase inhibitors in combination with microtubule-targeting agents prompted us to design and develop single agents that possess both epidermal growth factor receptor (EGFR) kinase and tubulin polymerization inhibitory properties. A series of 6-aryl/heteroaryl-4-(3',4',5'-trimethoxyanilino)thieno[3,2- d]pyrimidine derivatives were discovered as novel dual tubulin polymerization and EGFR kinase inhibitors. The 4-(3',4',5'-trimethoxyanilino)-6-( p-tolyl)thieno[3,2- d]pyrimidine derivative 6g was the most potent compound of the series as an antiproliferative agent, with half-maximal inhibitory concentration (IC50) values in the single- or double-digit nanomolar range. Compound 6g bound to tubulin in the colchicine site and inhibited tubulin assembly with an IC50 value of 0.71 μM, and 6g inhibited EGFR activity with an IC50 value of 30 nM. Our data suggested that the excellent in vitro and in vivo profile of 6g may be derived from its dual inhibition of tubulin polymerization and EGFR kinase.

UI MeSH Term Description Entries
D008870 Microtubules Slender, cylindrical filaments found in the cytoskeleton of plant and animal cells. They are composed of the protein TUBULIN and are influenced by TUBULIN MODULATORS. Microtubule
D011065 Poly(ADP-ribose) Polymerases Enzymes that catalyze the transfer of multiple ADP-RIBOSE groups from nicotinamide-adenine dinucleotide (NAD) onto protein targets, thus building up a linear or branched homopolymer of repeating ADP-ribose units i.e., POLY ADENOSINE DIPHOSPHATE RIBOSE. ADP-Ribosyltransferase (Polymerizing),Poly ADP Ribose Polymerase,Poly(ADP-Ribose) Synthase,Poly(ADP-ribose) Polymerase,PARP Polymerase,Poly ADP Ribose Transferase,Poly ADP-Ribose Synthase,Poly(ADP-Ribose) Transferase,Poly(ADPR) Polymerase,Poly(ADPribose) Polymerase,Poly ADP Ribose Synthase,Polymerase, PARP,Synthase, Poly ADP-Ribose
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D003078 Colchicine A major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. Its primary therapeutic use is in the treatment of gout, but it has been used also in the therapy of familial Mediterranean fever (PERIODIC DISEASE). Colchicine, (+-)-Isomer,Colchicine, (R)-Isomer
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014404 Tubulin A microtubule subunit protein found in large quantities in mammalian brain. It has also been isolated from SPERM FLAGELLUM; CILIA; and other sources. Structurally, the protein is a dimer with a molecular weight of approximately 120,000 and a sedimentation coefficient of 5.8S. It binds to COLCHICINE; VINCRISTINE; and VINBLASTINE. alpha-Tubulin,beta-Tubulin,delta-Tubulin,epsilon-Tubulin,gamma-Tubulin,alpha Tubulin,beta Tubulin,delta Tubulin,epsilon Tubulin,gamma Tubulin

Related Publications

Romeo Romagnoli, and Filippo Prencipe, and Paola Oliva, and Stefania Baraldi, and Pier Giovanni Baraldi, and Santiago Schiaffino Ortega, and Mariem Chayah, and Maria Kimatrai Salvador, and Luisa Carlota Lopez-Cara, and Andrea Brancale, and Salvatore Ferla, and Ernest Hamel, and Roberto Ronca, and Roberta Bortolozzi, and Elena Mariotto, and Elena Mattiuzzo, and Giampietro Viola
September 2017, European journal of medicinal chemistry,
Romeo Romagnoli, and Filippo Prencipe, and Paola Oliva, and Stefania Baraldi, and Pier Giovanni Baraldi, and Santiago Schiaffino Ortega, and Mariem Chayah, and Maria Kimatrai Salvador, and Luisa Carlota Lopez-Cara, and Andrea Brancale, and Salvatore Ferla, and Ernest Hamel, and Roberto Ronca, and Roberta Bortolozzi, and Elena Mariotto, and Elena Mattiuzzo, and Giampietro Viola
December 2019, Chemical biology & drug design,
Romeo Romagnoli, and Filippo Prencipe, and Paola Oliva, and Stefania Baraldi, and Pier Giovanni Baraldi, and Santiago Schiaffino Ortega, and Mariem Chayah, and Maria Kimatrai Salvador, and Luisa Carlota Lopez-Cara, and Andrea Brancale, and Salvatore Ferla, and Ernest Hamel, and Roberto Ronca, and Roberta Bortolozzi, and Elena Mariotto, and Elena Mattiuzzo, and Giampietro Viola
November 2017, Chemical biology & drug design,
Romeo Romagnoli, and Filippo Prencipe, and Paola Oliva, and Stefania Baraldi, and Pier Giovanni Baraldi, and Santiago Schiaffino Ortega, and Mariem Chayah, and Maria Kimatrai Salvador, and Luisa Carlota Lopez-Cara, and Andrea Brancale, and Salvatore Ferla, and Ernest Hamel, and Roberto Ronca, and Roberta Bortolozzi, and Elena Mariotto, and Elena Mattiuzzo, and Giampietro Viola
May 2024, Bioorganic chemistry,
Romeo Romagnoli, and Filippo Prencipe, and Paola Oliva, and Stefania Baraldi, and Pier Giovanni Baraldi, and Santiago Schiaffino Ortega, and Mariem Chayah, and Maria Kimatrai Salvador, and Luisa Carlota Lopez-Cara, and Andrea Brancale, and Salvatore Ferla, and Ernest Hamel, and Roberto Ronca, and Roberta Bortolozzi, and Elena Mariotto, and Elena Mattiuzzo, and Giampietro Viola
December 2011, Journal of medicinal chemistry,
Romeo Romagnoli, and Filippo Prencipe, and Paola Oliva, and Stefania Baraldi, and Pier Giovanni Baraldi, and Santiago Schiaffino Ortega, and Mariem Chayah, and Maria Kimatrai Salvador, and Luisa Carlota Lopez-Cara, and Andrea Brancale, and Salvatore Ferla, and Ernest Hamel, and Roberto Ronca, and Roberta Bortolozzi, and Elena Mariotto, and Elena Mattiuzzo, and Giampietro Viola
February 2020, European journal of medicinal chemistry,
Romeo Romagnoli, and Filippo Prencipe, and Paola Oliva, and Stefania Baraldi, and Pier Giovanni Baraldi, and Santiago Schiaffino Ortega, and Mariem Chayah, and Maria Kimatrai Salvador, and Luisa Carlota Lopez-Cara, and Andrea Brancale, and Salvatore Ferla, and Ernest Hamel, and Roberto Ronca, and Roberta Bortolozzi, and Elena Mariotto, and Elena Mattiuzzo, and Giampietro Viola
January 2019, Bioorganic & medicinal chemistry letters,
Romeo Romagnoli, and Filippo Prencipe, and Paola Oliva, and Stefania Baraldi, and Pier Giovanni Baraldi, and Santiago Schiaffino Ortega, and Mariem Chayah, and Maria Kimatrai Salvador, and Luisa Carlota Lopez-Cara, and Andrea Brancale, and Salvatore Ferla, and Ernest Hamel, and Roberto Ronca, and Roberta Bortolozzi, and Elena Mariotto, and Elena Mattiuzzo, and Giampietro Viola
December 2017, Bioorganic & medicinal chemistry,
Romeo Romagnoli, and Filippo Prencipe, and Paola Oliva, and Stefania Baraldi, and Pier Giovanni Baraldi, and Santiago Schiaffino Ortega, and Mariem Chayah, and Maria Kimatrai Salvador, and Luisa Carlota Lopez-Cara, and Andrea Brancale, and Salvatore Ferla, and Ernest Hamel, and Roberto Ronca, and Roberta Bortolozzi, and Elena Mariotto, and Elena Mattiuzzo, and Giampietro Viola
April 2012, Journal of medicinal chemistry,
Romeo Romagnoli, and Filippo Prencipe, and Paola Oliva, and Stefania Baraldi, and Pier Giovanni Baraldi, and Santiago Schiaffino Ortega, and Mariem Chayah, and Maria Kimatrai Salvador, and Luisa Carlota Lopez-Cara, and Andrea Brancale, and Salvatore Ferla, and Ernest Hamel, and Roberto Ronca, and Roberta Bortolozzi, and Elena Mariotto, and Elena Mattiuzzo, and Giampietro Viola
June 2024, European journal of medicinal chemistry,
Copied contents to your clipboard!